Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Greenpine Pharmaceutical imports, registers, and commercializes innovative drugs and medical devices in China, specializing in endoscopic surgery product lines and finished dosage forms such as injectables and oral solids. It partners with overseas pharmaceutical and device manufacturers to bring products to the Chinese market, with notable commercialization of post-surgical anti-adhesion medical devices and oncology injectables. Clinical results for flagship devices such as Medicurtain are supported by large-scale trials by original developers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Greenpine Pharmaceutical.